Ngo-1994, kwaqhamuka isikhungo socwaningo lweJintan Deveri. After more than 20 years of struggle and innovation, the company officially changed its name to Jiangsu Jingye Pharmaceutical Co., Ltd. on May 16, 2016, and obtained the Drug Manufacturing License for Loratadine, Crotamiton, Amitriptyline Hydrochloride and other drugs.
Ngamashumishumi eminyaka wokuphikelela okungaguquki nemizamo, imikhiqizo kaJingye yemithi yezemithi iwine indumiso ephezulu evela kumakhasimende asekhaya nakwamanye amazwe. Imikhiqizo yenkampani ithunyelwe ngaphandle eYurophu naseMelika futhi yathola ukubhaliswa kwe-DMF kanye nesitifiketi se-DUN & Bradststreet.
Ngamashumishumi eminyaka wokuphikelela okungaguquki nemizamo, imikhiqizo kaJingye yemithi yezemithi iwine indumiso ephezulu evela kumakhasimende asekhaya nakwamanye amazwe. Imikhiqizo yenkampani ithunyelwe ngaphandle eYurophu naseMelika futhi yathola ukubhaliswa kwe-DMF kanye nesitifiketi se-DUN & Bradststreet.